首页> 美国卫生研究院文献>Journal of Virology >Identification of Dominant Negative Human Immunodeficiency Virus Type 1 Vif Mutants That Interfere with the Functional Inactivation of APOBEC3G by Virus-Encoded Vif
【2h】

Identification of Dominant Negative Human Immunodeficiency Virus Type 1 Vif Mutants That Interfere with the Functional Inactivation of APOBEC3G by Virus-Encoded Vif

机译:鉴定主要的人免疫缺陷病毒1型Vif突变体这些突变体会干扰病毒编码的Vif对APOBEC3G的功能失活

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

APOBEC3G (A3G) is a host cytidine deaminase that serves as a potent intrinsic inhibitor of retroviral replication. A3G is packaged into human immunodeficiency virus type 1 virions and deaminates deoxycytidine to deoxyuridine on nascent minus-strand retroviral cDNA, leading to hyper-deoxyguanine-to-deoxyadenine mutations on positive-strand cDNA and inhibition of viral replication. The antiviral activity of A3G is suppressed by Vif, a lentiviral accessory protein that prevents encapsidation of A3G. In this study, we identified dominant negative mutants of Vif that interfered with the ability of wild-type Vif to inhibit the encapsidation and antiviral activity of A3G. These mutants were nonfunctional due to mutations in the highly conserved HCCH and/or SOCS box motifs, which are required for assembly of a functional Cul5-E3 ubiquitin ligase complex. Similarly, mutation or deletion of a PPLP motif, which was previously reported to be important for Vif dimerization, induced a dominant negative phenotype. Expression of dominant negative Vif counteracted the Vif-induced reduction of intracellular A3G levels, presumably by preventing Vif-induced A3G degradation. Consequently, dominant negative Vif interfered with wild-type Vif's ability to exclude A3G from viral particles and reduced viral infectivity despite the presence of wild-type Vif. The identification of dominant negative mutants of Vif presents exciting possibilities for the design of novel antiviral strategies.
机译:APOBEC3G(A3G)是一种宿主胞苷脱氨酶,可作为逆转录病毒复制的有效内在抑制剂。将A3G包装到人免疫缺陷病毒1型病毒体中,并在新生的负链逆转录病毒cDNA上将脱氧胞苷脱氨基为脱氧尿苷,从而导致正链cDNA发生高脱氧鸟嘌呤至脱氧腺嘌呤突变,并抑制病毒复制。 Vif是一种防止A3G衣壳化的慢病毒辅助蛋白,可抑制A3G的抗病毒活性。在这项研究中,我们确定了Vif的显性负突变体,这些突变体干扰了野生型Vif抑制A3G的衣壳化和抗病毒活性。这些突变体由于高度保守的HCCH和/或SOCS盒基序中的突变而无功能,而这些是组装功能性Cul5-E3泛素连接酶复合物所必需的。同样,以前据报道对Vif二聚化很重要的PPLP基序的突变或缺失诱导了显性负表型。显性负性Vif的表达通过阻止Vif诱导的A3G降解来抵消Vif诱导的细胞内A3G水平降低。因此,尽管存在野生型Vif,但显性阴性Vif干扰了野生型Vif从病毒颗粒中排除A3G的能力,并降低了病毒的传染性。 Vif的显性负突变体的鉴定为新型抗病毒策略的设计提供了令人兴奋的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号